SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041606
Filing Date
2021-08-05
Accepted
2021-08-05 16:19:13
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srra-10q_20210630.htm   iXBRL 10-Q 2494633
2 EX-31.1 srra-ex311_9.htm EX-31.1 9803
3 EX-31.2 srra-ex312_8.htm EX-31.2 9806
4 EX-32.1 srra-ex321_7.htm EX-32.1 7247
5 EX-32.2 srra-ex322_6.htm EX-32.2 7310
  Complete submission text file 0001564590-21-041606.txt   7649297

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srra-20210630.xsd EX-101.SCH 48412
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20210630_cal.xml EX-101.CAL 42424
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20210630_def.xml EX-101.DEF 147617
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20210630_lab.xml EX-101.LAB 378110
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20210630_pre.xml EX-101.PRE 272444
11 EXTRACTED XBRL INSTANCE DOCUMENT srra-10q_20210630_htm.xml XML 1335831
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 211148484
SIC: 2834 Pharmaceutical Preparations